Stephen Hahn, M.D., Chief Medical Executive of The University of Texas MD Anderson Cancer Center, is reported to be a top candidate for the FDA Commissioner's position.
Stephen Hahn, M.D., Chief Medical Executive of The University of Texas MD Anderson Cancer Center, is the top candidate to be the next commissioner of the U.S. Food and Drug Administration (FDA).
According to multiple reports, President Donald Trump is set to name Hahn as a permanent replacement for Scott Gottlieb, who resigned from his role in March. A new acting commissioner or a permanent replacement should be named by Nov. 1 to comply with the terms of the Federal Vacancies Reform Act.
Prior to his role as the Chief Medical Executive of MD Anderson, Hahn was the Deputy President and Chief Operating Officer until his current appointment in 2018.
U.S. FDA acting commissioner and former Director of the National Cancer Institute Norman (Ned) Sharpless will remain in place throughout the confirmation hearings if Hahn is nominated. Once the appointment has been confirmed, Sharpless can return to his previous role at the institute.
